RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

National Health and Medical Research Council, Australia

Hunter Medical Research Institute (HMRI)

Health Research Council, New Zealand

Novartis Pharmaceuticals

Abbott

Information provided by (Responsible Party):

Trans-Tasman Radiation Oncology Group (TROG)

ClinicalTrials.gov Identifier:

NCT00193856

First received: September 12, 2005

Last updated: June 21, 2012

Last verified: June 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2018
Estimated Primary Completion Date:	July 2017 (Final data collection date for primary outcome measure)

Publications:

Haworth A, Kearvell R, Greer PB, Hooton B, Denham JW, Lamb D, Duchesne G, Murray J, Joseph D. Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study. Radiotherapy and Oncology 90 (2009) 299-306

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Denham JW, Wilcox C, Joseph D, Spry NA, Lamb DS, Tai KH, Matthews J, Atkinson C, Turner S, Christie D, Gogna NK, Kenny L, Duchesne G, Delahunt B, McElduff P. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. Lancet Oncol. 2012 Dec;13(12):1260-70. doi: 10.1016/S1470-2045(12)70423-0. Epub 2012 Nov 12. PubMed PMID: 23151431.

Denham JW, Wilcox C, Lamb DS, Spry NA, Duchesne G, Atkinson C, Matthews J, Turner S, Kenny L, Tai KH, Gogna NK, Ebert M, Delahunt B, McElduff P, Joseph D. Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer. Radiother Oncol. 2012 Nov;105(2):184-92. doi: 10.1016/j.radonc.2012.09.018. Epub 2012 Nov 3.

To Top